Why the study?
Does dobutamine echocardiographic test (DET) response predict transplant-free survival and clinical improvement in patients with idiopathic dilated cardiomyopathy?
Population
51 patients with idiopathic dilated cardiomyopathy treated with optimal medical therapy, including…
Design
Cohort
Follow-up
34+/-16 months
Authors
Loading...
DET adds only modest incremental sensitivity for transplant-free survival; leaves open its clinical utility beyond standard evaluation in idiopathic dilated cardiomyopathy.
Does dobutamine echocardiographic test (DET) response predict transplant-free survival and clinical improvement in patients with idiopathic dilated cardiomyopathy?
While a positive dobutamine echocardiography test indicates an earlier disease stage and better outcome in idiopathic dilated cardiomyopathy, its incremental prognostic value over clinical evaluation is limited.
Pinamonti et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: